Cardiologie

De vakgroep beoefent de cardiologie in al haar diagnostische en therapeutische mogelijkheden.

Er is een 24 uur/7 dagen per week STEMI-zorg voor het adherentiegebied van het ASz en Beatrixziekenhuis.

De interventiecardiologen doen meer dan 1200 PCI’s jaarlijks. Er bestaat een samenwerkingsverband met het Beatrixziekenhuis in Gorinchem voor de interventiecardiologie, niet-invasieve beeldvorming, ICD en cardiale resynchronisatietherapie. Er bestaat tevens een samenwerkingsverband met het Erasmus MC op het gebied van de electrofysiologie, thoraxchirurgie, interventiecardiologie, de B-opleiding cardiologie en behandeling van congenitale hartziekten.

Er lopen verschillende onderzoekslijnen met origineel wetenschappelijk onderzoek. Samen met de vakgroep radiologie wordt cardiaal MRI- en CT-onderzoek verricht. Er is een vermelding op de witte lijst van de NVVC voor zowel de percutane coronaire interventies als ICD-implantaties. Procedure data en follow-up van zowel PM/ICD’s als PCI’s worden geregistreerd in de landelijke NCDR database. Er is een level 3 IC in het ASz.

Leden

M. (Micon) Bijl

M. (Micon) Bijl

Cardiologie

BIG: 29020421101

dr. E.J. (Ewout-Jan) van den Bos

dr. E.J. (Ewout-Jan) van den Bos

Cardiologie

BIG: 29057046501

A. (Attila) Dirkali

A. (Attila) Dirkali

Cardiologie

BIG: 09044772601

dr. M.W.F. (Marco) van Gent

dr. M.W.F. (Marco) van Gent

Cardiologie

BIG: 29060453001

M.J.M. (Maurice) Kurvers

M.J.M. (Maurice) Kurvers

Cardiologie

BIG: 59049084501

M. (Martijn) Scholte

M. (Martijn) Scholte

Cardiologie

BIG: 49057968601

A.P.J.D. (Auke) Weevers

A.P.J.D. (Auke) Weevers

Cardiologie

BIG: 79058214901

dr. L.J.P.M. (Léon) van Woerkens

dr. L.J.P.M. (Léon) van Woerkens

Cardiologie

BIG: 39041690401

A.M. (Anne Mijntje) Helming

A.M. (Anne Mijntje) Helming

Cardiologie, medisch manager vakgroep

BIG: 69065887501

C. (Crista) Liesting

C. (Crista) Liesting

Cardiologie

BIG: 69909135001

dr. F. (Floris) Kauer

dr. F. (Floris) Kauer

Interventiecardiologie

BIG: 99059681201

dr. R.M. (Rohit) Oemrawsingh

dr. R.M. (Rohit) Oemrawsingh

Interventiecardiologie

BIG: 29909182301

dr. J.O. (John) Younge

dr. J.O. (John) Younge

Cardioloog (aandachtsgebied hartfalen)

BIG: 89915145301

Dordwijk

J.M. (Jin) Cheng

J.M. (Jin) Cheng

Interventiecardioloog

BIG: 89915153301

Dordwijk

Publicaties

01sep

Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction

01jul

Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort.

01jun

Impact of Multisite artery disease on Clinical Outcomes After Percutaneous Coronary Intervention: An Analysis from the e-Ultimaster Registry.

01mei

Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial.

01apr

Serially Measured hs-cTnT, NT-proBNP, hs-CRP and GDF-15 for Risk Assessment After Acute Coronary Syndrome: the BIOMArCS Cohort.

01apr

Mitochondrial Cardiomyopathy: Distinctive Cardiac Phenotype Detected with Cardiovascular MRI.

01mrt

Regional management of worsening heart failure: rationale and design of the CHAIN-HF registry.

01mrt

Sex-related bleeding risk in acute coronary syndrome patients receiving dual antiplatelet therapy with aspirin and a P2Y12 inhibitor.

01mrt

Risk of cancer after ST-segment-elevation myocardial infarction.

01jan

Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and prognosis in acute heart failure.

01jan

Longitudinal profile of circulating endothelial cells in post-acute coronary syndrome patients.

01dec

A rare finding on computed tomography angiography performed to exclude pulmonary embolism.

01dec

Pharmaco-invasive therapy: Early implementation of statins and proprotein convertase subtilisin/kexin type 9 inhibitors after acute coronary syndrome.

01nov

Prognostic value of syntax score, intravascular ultrasound and near-infrared spectroscopy to identify low-risk patients with coronary artery disease 5-year results from the ATHEROREMO and IBIS-3 cohorts.

01nov

Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and prognosis in acute heart failure.

01nov

Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial.

01nov

Final 5-year report of the randomized BIO-RESORT trial comparing 3 contemporary drug-eluting stents in all-comers.

01sep

Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma.

01aug

The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.

01aug

The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.

01aug

Clinical Outcomes of Percutaneous Coronary Intervention for Bifurcation Lesions According to Medina Classification.

01jun

Predictive Value of the (Quick)DASH Tool for Upper Extremity Dysfunction Following Percutaneous Coronary Intervention.

01mei

Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT-FFR Trial.

01apr

The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.

01mrt

Treatment and Management of Upper Extremity Dysfunction Following Transradial Percutaneous Coronary Intervention: A Prospective Cohort Study.

01mrt

Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial.

01jan

Relation of Iron Status to Prognosis After Acute Coronary Syndrome.

01nov

2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab.

01sep

R on the side of caution.

01jul

Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.

01jul

Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction JQ1d residual nonflow limiting lesions: rationale and design of the PECTUS-obs study.

01jun

Usefulness of High-Sensitivity Cardiac Troponin T to Predict Long-Term Outcome in Patients with Hypertrophic Cardiomyopathy.

01jun

Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death.

01apr

Brachial Artery Thrombosis as a Presentation of Non-Small Cell Pulmonary Carcinoma Growing Into the Left Atrium.

01jan

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

01jan

Coronary bifurcations treated with thin-strut drug-eluting stents: a prespecified analysis of the randomized BIO-RESORT trial.

01dec

High-Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission

10nov

Comparison of two iterations of the zotarolimus-eluting stents: an analysis of all-comer patients from two consecutive randomised clinical trials.

01nov

ONCOR: design of the Dutch cardio-oncology registry.

01okt

One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registries.

01okt

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials

01okt

Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.

01okt

Pacing in hypertrophic obstructive cardiomyopathy: First choice therapy in low volume centers?

01jul

Left ventricular inflow obstruction and shock due to herniated peritoneal sac filled with ascites.

01jul

Impact of Machine-Learning CT-derived Fractional Flow Reserve for the Diagnosis and Management of Coronary Artery Disease in the Randomized CRESCENT Trials.

01jun

Patient Profiles and Health Status Outcomes for Peripheral Artery Disease in High-Income Countries: A Comparison Between the United States and the Netherlands.

01mei

Comparison of temporal changes in established cardiovascular biomarkers after acute coronary syndrome between Caucasian and Chinese patients with diabetes mellitus.

     

01mei

Treatment Differences in Chronic Heart Failure Patients With Reduced Ejection Fraction According to Blood Pressure.

   

01mei

Presence of a giant mass in the interventricular septum with long follow-up.

01apr

Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trial.

01apr

Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice.

01feb

Increase in Coronary Lumen Area and Stent Apposition After Treatment of CTO Using a Coronary Self-Expanding Stent.

01jan

Exercise and myocardial injury in hypertrophic cardiomyopathy.

   

01jan

Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.

01jan

A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.

01jan

A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trial.

01jan

The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy.

Beeldmateriaal

of login met gebruikersnaam